“Drug market imbalance is bad for patient health, and counter intuitive for modern health needs. We seek to redress this balance.”
ALISON BUTTERWORTH, Quality
Responding to how drugs are prescribed
Even after many years of use, new clinical data can rapidly change how healthcare professionals prescribe drugs. This can lead to increased demand for some treatments – but if sufficient market supply isn’t in place, the result can be higher prices and reduced access for patients.
We look to address this imbalance, by using our knowledge and expertise to identify specific disease areas and reintroduce products to market. We give patients better access to medications, to improve their quality of life.
Supplying essential treatments
It only takes one patient support group to advocate for another product to cause a shift in demand. This can cause supply instability and ultimately result in drug shortages, restricting essential treatments when they are needed most.
We constantly monitor markets for these persistent shifts and develop products to alleviate these shortages. This ensures that patients are able to access the drugs they require, and ensures the market remains competitive in pricing of drugs.